CN1840133A - Six-ingredient tablet containing pomegranate - Google Patents
Six-ingredient tablet containing pomegranate Download PDFInfo
- Publication number
- CN1840133A CN1840133A CN 200610008437 CN200610008437A CN1840133A CN 1840133 A CN1840133 A CN 1840133A CN 200610008437 CN200610008437 CN 200610008437 CN 200610008437 A CN200610008437 A CN 200610008437A CN 1840133 A CN1840133 A CN 1840133A
- Authority
- CN
- China
- Prior art keywords
- raw materials
- time
- magnesium stearate
- flos carthami
- thick paste
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
Abstract
The invention relates to a Tibetan tablet preparation for warming the kidney and waist, wherein the raw materials include pomegranate 80-110g, Cinnamomum cassia, mace nutmeg, piper nigrum, safflower 30-60g, starch 12-25g and right amount of magnesium stearate.
Description
One, technical field: the invention belongs to the Tibetan medicine technical field, particularly a kind of six-ingredient tablet containing pomegranate with the kidney warming, warm waist knee joint function.
Two, technical background: have the medicine product-free that is used for the treatment of women leucorrhea disease of the kidney warming, warm waist knee joint function in the market, this medicine is original product invention.
Three, summary of the invention:
The objective of the invention is at the prior art above shortcomings, and develop a kind of six-ingredient tablet containing pomegranate.This tablet has the kidney warming, warm waist knee joint effect, and it is applicable to the disease of treatment women leucorrhea disease.
Technical scheme is: this six-ingredient tablet containing pomegranate is made by following proportioning raw materials and manufacture method: (one) proportioning raw materials is the quality weight ratio, Punica granatum L. 80～110g, Cortex Cinnamomi 30～60g, Semen Myristicae 30～60g, Fructus Piperis 30～60g, Flos Carthami 30～60g, Ramulus seu Fructus Caesalpiniae 30～60g, starch 12～25g, magnesium stearate 4～12g; (2) manufacture method is: above-mentioned medicinal raw material is pressed the above-mentioned raw materials proportion ingredient, get Punica granatum L., Cortex Cinnamomi, Semen Myristicae three flavor raw material mixing and water addings decoct 2～3 times, decocted 1.5～2.5 hours for the first time, for the second time, respectively decocted for the third time 0.5～1.5 hour, collecting decoction, filter and remove residue, filtrate concentrates anhydrates that to make thick paste standby, Fructus Piperis, Flos Carthami, Ramulus seu Fructus Caesalpiniae is ground into fine powder, with thick paste mix homogeneously, drying, with the screening of 〉=80 mesh standard sieves, the siftage fine powder is made granule with ethanol behind the pulverizing process, drying adds starch again, magnesium stearate mixing tabletting gets product.Thick paste is meant the thick liquid higher slightly than extractum water content, and the present invention considers for next step operation adds the bigger powder of quantity.
The prescription uniqueness of this tablet, manufacture method makes with modern crafts, and it has kept effective effect composition of raw material as far as possible, has effectively overcome the deficiencies in the prior art.This tablet have dosage accurately, steady quality is difficult for going mouldy, tablet does not have solvent, volume is little, takes and advantage such as easy to carry.Every day 2～3 times when taking, each 3～5.
Four, the specific embodiment:
Embodiment one: get Punica granatum L. 80g, Cortex Cinnamomi 30g, Semen Myristicae 30g, Fructus Piperis, Flos Carthami, Ramulus seu Fructus Caesalpiniae is respectively got 60g, starch 12g, magnesium stearate 12g prepares burden, Punica granatum L., Cortex Cinnamomi, the Semen Myristicae mixing and water adding decocts 2 times, decocts 2.5 hours for the first time, decocts 1.5 hours for the second time, collecting decoction, filter concentrated the anhydrating of filtrate and make thick paste, Fructus Piperis, Flos Carthami, Ramulus seu Fructus Caesalpiniae is ground into fine powder, with the thick paste mixing, drying, after the pulverizing, after the screening of 80 purpose standard screens, the siftage ethanol content is 60% alcohol granulation, drying adds starch again, magnesium stearate mixing tabletting gets product.
Embodiment two: get Punica granatum L. 110g, Cortex Cinnamomi 60g, Semen Myristicae 60g, Fructus Piperis, Flos Carthami, each 30g of Ramulus seu Fructus Caesalpiniae, starch 25g, magnesium stearate 4g batching, Punica granatum L., Cortex Cinnamomi, the Semen Myristicae mixing and water adding decocts 3 times, decocted 1.5 hours for the first time, for the second time, respectively decocted collecting decoction for the third time 0.5 hour, filter concentrated the anhydrating of filtrate and make thick paste, Fructus Piperis, Flos Carthami, Ramulus seu Fructus Caesalpiniae is ground into fine powder, mixes drying with thick paste, after the pulverizing, with the screening of 120 mesh standard sieves, the siftage ethanol content is 15% alcohol granulation, and the operation of back is identical with embodiment one.
Embodiment three: get Punica granatum L. 1.0kg, Cortex Cinnamomi 0.55kg, Semen Myristicae 0.45kg, Fructus Piperis 0.35kg, Flos Carthami 0.35kg, Ramulus seu Fructus Caesalpiniae are respectively got 0.45kg, starch 0.10kg, and magnesium stearate 0.10kg prepares burden, and the back manufacturing process is identical with embodiment two.
Claims (1)
1. six-ingredient tablet containing pomegranate, it is characterized in that it is made by following proportioning raw materials and manufacture method: (one) proportioning raw materials is the quality weight ratio, Punica granatum L. 80～110g, Cortex Cinnamomi 30～60g, Semen Myristicae 30～60g, Fructus Piperis 30～60g, Flos Carthami 30～60g, Ramulus seu Fructus Caesalpiniae 30～60g, starch 12～25g, magnesium stearate 4～12g; (2) manufacture method is: above-mentioned medicinal raw material is pressed the above-mentioned raw materials proportion ingredient, get Punica granatum L., Cortex Cinnamomi, Semen Myristicae three flavor raw material mixing and water addings decoct 2～3 times, decocted 1.5～2.5 hours for the first time, for the second time, respectively decocted for the third time 0.5～1.5 hour, collecting decoction, filter and remove residue, filtrate concentrates anhydrates that to make thick paste standby, Fructus Piperis, Flos Carthami, Ramulus seu Fructus Caesalpiniae is ground into fine powder, with thick paste mix homogeneously, drying, behind the pulverizing process, sieve with 〉=80 mesh standard sieves, the siftage fine powder is made granule with ethanol, and drying adds starch again, magnesium stearate mixing tabletting gets product.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 200610008437 CN1840133A (en) | 2006-01-21 | 2006-01-21 | Six-ingredient tablet containing pomegranate |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 200610008437 CN1840133A (en) | 2006-01-21 | 2006-01-21 | Six-ingredient tablet containing pomegranate |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN1840133A true CN1840133A (en) | 2006-10-04 |
Family
ID=37029436
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 200610008437 Pending CN1840133A (en) | 2006-01-21 | 2006-01-21 | Six-ingredient tablet containing pomegranate |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1840133A (en) |
Cited By (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105616524A (en) * | 2016-03-30 | 2016-06-01 | 济南新时代医药科技有限公司 | Application of six-flavor pomegranate tablet to preparation of cell proliferation drug for restraining B lymphocyte tumor cells Daudi |
| CN105616523A (en) * | 2016-03-30 | 2016-06-01 | 济南新时代医药科技有限公司 | Application of six-flavor pomegranate tablet to preparation of cell proliferation drug for restraining neuroblastoma cells M17 |
| CN105726651A (en) * | 2016-03-30 | 2016-07-06 | 济南新时代医药科技有限公司 | Application of Liuweishiliu tablet to preparation of drugs for inhibiting cutaneous melanoma cell SK-HEL-1 proliferation |
| CN105726650A (en) * | 2016-03-30 | 2016-07-06 | 济南新时代医药科技有限公司 | Application of Liuweishiliu tablet to preparation of drugs for inhibiting malignant brain glioma cell SHG-44 proliferation |
| CN105726649A (en) * | 2016-03-30 | 2016-07-06 | 济南新时代医药科技有限公司 | Application of Liuweishiliu tablet to preparation of drugs for inhibiting uterine well-differentiated squamous carcinoma cell HCC proliferation |
| CN105796661A (en) * | 2016-03-30 | 2016-07-27 | 济南新时代医药科技有限公司 | Application of six-flavor pomegranate tablets to preparation of drug for restraining T cell leukemia cell HPB-ALL cell proliferation |
| CN105796660A (en) * | 2016-03-30 | 2016-07-27 | 济南新时代医药科技有限公司 | Application of six-flavor pomegranate tablets to preparation of drug for restraining neurogliocytoma cell U251 cell proliferation |
| CN105816530A (en) * | 2016-03-30 | 2016-08-03 | 济南新时代医药科技有限公司 | Application of six-ingredient pomegranate tablets in preparation of drug for inhibiting cell proliferation of skin basal cell carcinoma cells A431 |
| CN105832825A (en) * | 2016-03-30 | 2016-08-10 | 济南新时代医药科技有限公司 | Use of tablet of six ingredients with pomegranate seeds in preparation of drug for inhibiting brain tumor cell SF126 proliferation |
-
2006
- 2006-01-21 CN CN 200610008437 patent/CN1840133A/en active Pending
Cited By (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105616524A (en) * | 2016-03-30 | 2016-06-01 | 济南新时代医药科技有限公司 | Application of six-flavor pomegranate tablet to preparation of cell proliferation drug for restraining B lymphocyte tumor cells Daudi |
| CN105616523A (en) * | 2016-03-30 | 2016-06-01 | 济南新时代医药科技有限公司 | Application of six-flavor pomegranate tablet to preparation of cell proliferation drug for restraining neuroblastoma cells M17 |
| CN105726651A (en) * | 2016-03-30 | 2016-07-06 | 济南新时代医药科技有限公司 | Application of Liuweishiliu tablet to preparation of drugs for inhibiting cutaneous melanoma cell SK-HEL-1 proliferation |
| CN105726650A (en) * | 2016-03-30 | 2016-07-06 | 济南新时代医药科技有限公司 | Application of Liuweishiliu tablet to preparation of drugs for inhibiting malignant brain glioma cell SHG-44 proliferation |
| CN105726649A (en) * | 2016-03-30 | 2016-07-06 | 济南新时代医药科技有限公司 | Application of Liuweishiliu tablet to preparation of drugs for inhibiting uterine well-differentiated squamous carcinoma cell HCC proliferation |
| CN105796661A (en) * | 2016-03-30 | 2016-07-27 | 济南新时代医药科技有限公司 | Application of six-flavor pomegranate tablets to preparation of drug for restraining T cell leukemia cell HPB-ALL cell proliferation |
| CN105796660A (en) * | 2016-03-30 | 2016-07-27 | 济南新时代医药科技有限公司 | Application of six-flavor pomegranate tablets to preparation of drug for restraining neurogliocytoma cell U251 cell proliferation |
| CN105816530A (en) * | 2016-03-30 | 2016-08-03 | 济南新时代医药科技有限公司 | Application of six-ingredient pomegranate tablets in preparation of drug for inhibiting cell proliferation of skin basal cell carcinoma cells A431 |
| CN105832825A (en) * | 2016-03-30 | 2016-08-10 | 济南新时代医药科技有限公司 | Use of tablet of six ingredients with pomegranate seeds in preparation of drug for inhibiting brain tumor cell SF126 proliferation |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1840133A (en) | Six-ingredient tablet containing pomegranate | |
| CA2467444A1 (en) | Medicament for treatment of climacteric syndrome of women and preparation method thereof | |
| CN102133331B (en) | Capsule with function of improving sleeping quality and preparation process | |
| CN1742842A (en) | External-use plaster for treating mumps | |
| CN102302609A (en) | Compound traditional Chinese drug preparation for improving subhealth | |
| CN102406714B (en) | Pharmaceutical composition favorable for defaecation and preparation method thereof | |
| CN101317890A (en) | Process for preparing capsule for urinary system lithiasis | |
| CN1827156A (en) | Consciousness-restoring tablet with pearl | |
| CN101317983A (en) | Method for preparing capsule for nourishing Yin and suppressing Yang, discharging fire and pacifying the mind | |
| CN102552812B (en) | Traumatic injury curative for external use and production method thereof | |
| CN109419847A (en) | A kind of fresh leonurus Radix Notoginseng Chinese medicine composition and preparation method thereof | |
| CN1242775C (en) | Bushenshansong drink and preparation method thereof | |
| CN106421489A (en) | Preparing method for blood glucose reducing substitute tea prepared by adopting edible plants as components | |
| CN1840132A (en) | Tablet for treating climacteric syndrome | |
| CN101317936A (en) | Method for preparing capsule for reliving liver and reliving upset | |
| CN1173719C (en) | Preparation of pile-eliminating turtle shell capsule | |
| CN1883682A (en) | Mind tranquilizing capsule | |
| CN101317924A (en) | Method for preparing capsule for tonifying the spleen and kidney | |
| CN101317949A (en) | Method for preparing capsule for nourishing blood, regulating menstruation and nourishing blood and liver | |
| CN102218120A (en) | Prescription of compound capsule for strengthening healthy energy and eliminating tumor and manufacture method thereof | |
| CN1883683A (en) | Mind tranquilizing tablet | |
| CN101317953A (en) | Method for preparing capsule for nourishing liquid, removing wind, nourishing Yin liquid | |
| CN1840135A (en) | Six-ingredient granule containing pomegranate | |
| CN1733191A (en) | Capsule for warming uterus and promoting pregnancy and process for preparing the same | |
| CN104491357A (en) | Traditional Chinese medicine composition as well as preparation method and application thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |